The VIGILANCE study: developing imaging and circulating biomarkers towards personalised radiotherapy in locally advanced lung cancer

Closing date: 17/11/2025

Clinical Research Training Fellowship: The VIGILANCE study: developing imaging and circulating biomarkers towards personalised radiotherapy in locally advanced lung cancer

Lead Supervisors: Prof. Corinne Faivre-Finn
Co-Supervisors: 
Dr Gareth Price, Dr Florent Mouliere

Applications Deadline: 12:00pm Monday 17th November 2025
Interviews: Week commencing 12th January 2026
Start date: September 2026

Project Keywords: Lung cancer, Radiotherapy, Biomarkers
Research Opportunity: Clinical Research Training Fellowship leading to the award of PhD

Project Outline

Lung cancer is the leading cause of cancer mortality worldwide with non-small-cell lung cancer (NSCLC) the most prevalent subtype. One-fifth of patients present with stage 3 or locally advanced (LA) disease (~ 9000/year in England). Over half of these patients receive radiotherapy-based treatments. In fit patients, concurrent chemoradiotherapy followed by immunotherapy offers the best chance of cure. However, this approach is associated with significant toxicity and outcomes remain poor due to high risk of disease recurrence.

There remains an unmet clinical need for biomarkers that can predict toxicity and identify treatment failure early. Such information would enable clinicians to personalise treatment and follow-up strategies, aligning care with patient and tumour characteristics. Our aim, therefore, is to design patient-led clinical trials that integrate new biomarkers to improve treatment decision-making and individualise lung cancer treatment.

High-quality, prospective clinical data has already been collected from patients with LA-NSCLC undergoing curative-intent radiotherapy within the MCRC VIGILANCE study. Study data includes innovative cell-free DNA (cfDNA) and radiomic biomarkers from routine imaging captured at multiple timepoints throughout treatment and follow-up. Patient-reported symptoms and quality of life measures have also been captured, using patient-reported outcome (PROMS). These will provide valuable insight into the patient experience of radiotherapy and permit the evaluation of PROMs as a patient-centred, qualitative biomarker. Except for cfDNA, all candidate biomarkers are routinely collected, making this study highly pragmatic and translatable to real-world practice.

Overall, this project builds on previous work but introduces new, impactful insights that will significantly advance the field. Importantly, it integrates patient involvement throughout which will inform the development of a patient co-designed trial, aimed at delivering more personalised care. The candidate will benefit from the unique infrastructure in Manchester that brings together experts in clinical and translational research in The Christie, National Biomarker Centre, and the MCRC.

Applications for this project are now open. Please complete your application on The University of Manchester website.

About Professor Corinne Faivre-Finn (project Lead Supervisor)

Corinne Faivre-Finn is a Professor of Thoracic Radiation Oncology at University of Manchester and Honorary Consultant Clinical Oncologist at the Christie.  She is an experienced PhD supervisor. 

She is Principal Investigator for numerous trials studying radiotherapy in lung cancer and an author of 24 lung cancer national and international guidelines. She has authored>300 papers including 7practice changing studies.  

She has numerous professional roles including radiotherapy research lead for Manchester Cancer Research Centre & CRUK Lung Cancer Centre, Chair of the ESTRO Lung Focus Group & the Early NSCLC EORTC Lung Group. She also leads the Christie Patient Reported Outcome Group.  

Find out more

Corinne Faivre-Finn

Key information

Before submitting an application, please ensure you have read the information below about the funding arrangements and eligibility for our Clinical Research Training Fellowships.

We also encourage you to get in contact with the lead supervisor to discuss the project and any particulars.

Further information is available on the Clinical Research Training Fellowships webpage.

Fees and Funding
Eligibility
How to apply
Applications Timelines

Useful Links

Submit your application

Interested in applying for this opportunity? Submit your application on The University of Manchester application portal.

Clinical Research Training Fellowships

Discover our various opportunities for clinicians looking to undertake a period of PhD training in a cancer-relevant field.

Get in Touch

Contact Dr Yasmin Noori Jenaghard, Postgraduate Programme Manager.

Researcher Stories

Read first-hand experiences of from cancer scientists from across Manchester.

Why Manchester?

Find out why postgraduate students choose to study in Manchester.

A Day in the Life of a Clinical PhD Student

Watch our short video to see what it's like to be a Clinical Research Training Fellow in Manchester.